484 related articles for article (PubMed ID: 8627112)
1. Viability of Mycobacterium leprae in skin and peripheral nerves and persistence of nerve destruction in multibacillary patients after 2 years of multidrug therapy.
Job CK; Jayakumar J; Aschhoff M; Mathan MM
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):44-50. PubMed ID: 8627112
[TBL] [Abstract][Full Text] [Related]
2. Are viable Mycobacterium leprae present in lepromatous patients after completion of 12 months' and 24 months' multi-drug therapy?
Ebenezer GJ; Daniel S; Norman G; Daniel E; Job CK
Indian J Lepr; 2004; 76(3):199-206. PubMed ID: 15835604
[TBL] [Abstract][Full Text] [Related]
3. Viability of Mycobacterium leprae in lepromatous patients after five years of dapsone monotherapy supplemented with two years of multidrug therapy.
Sivaprasad N; Snehalatha S; Lobo D; Aschhoff M; Job CK
Indian J Lepr; 1995; 67(4):427-33. PubMed ID: 8849919
[TBL] [Abstract][Full Text] [Related]
4. The effect of corticosteroids usage on bacterial killing, clearance and nerve damage in leprosy; part 3--Study of two comparable groups of 100 multibacillary (MB) patients each, treated with MDT + steroids vs. MDT alone, assessed at 6 months post-release from 12 months MDT.
Shetty VP; Khambati FA; Ghate SD; Capadia GD; Pai VV; Ganapati R
Lepr Rev; 2010 Mar; 81(1):41-58. PubMed ID: 20496569
[TBL] [Abstract][Full Text] [Related]
5. Nasal mucosa and skin of smear-positive leprosy patients after 24 months of fixed duration MDT: histopathological and microbiological study.
Ebenezer GJ; Job A; Abraham S; Arunthathi S; Rao PS; Job CK
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):292-7. PubMed ID: 10575409
[TBL] [Abstract][Full Text] [Related]
6. Persistence of Mycobacterium leprae in the peripheral nerve as compared to the skin of multidrug-treated leprosy patients.
Shetty VP; Suchitra K; Uplekar MW; Antia NH
Lepr Rev; 1992 Dec; 63(4):329-36. PubMed ID: 1479872
[TBL] [Abstract][Full Text] [Related]
7. Presence of M. leprae in tissues in slit skin smear negative multibacillary (MB) patients after WHO-MBR.
Sharma A; Sharma VK; Rajwanshi A; Das A; Kaur I; Kumar B
Lepr Rev; 1999 Sep; 70(3):281-6. PubMed ID: 10603717
[TBL] [Abstract][Full Text] [Related]
8. Higher incidence of viable Mycobacterium leprae within the nerve as compared to skin among multibacillary leprosy patients released from multidrug therapy.
Shetty VP; Suchitra K; Uplekar MW; Antia NH
Lepr Rev; 1997 Jun; 68(2):131-8. PubMed ID: 9217352
[TBL] [Abstract][Full Text] [Related]
9. Electron microscopic findings of the peripheral nerve lesions of nude mice inoculated with M. leprae.
Fukunishi Y
Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):75-8. PubMed ID: 3889194
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.
Cellona RV; Balagon MF; dela Cruz EC; Burgos JA; Abalos RM; Walsh GP; Topolski R; Gelber RH; Walsh DS
Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888
[TBL] [Abstract][Full Text] [Related]
11. Relapses in multibacillary leprosy patients after multidrug therapy.
Poojabylaiah M; Marne RB; Varikkodan R; Bala N; Dandakeri S; Martis J
Lepr Rev; 2008 Sep; 79(3):320-4. PubMed ID: 19009982
[TBL] [Abstract][Full Text] [Related]
12. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
[TBL] [Abstract][Full Text] [Related]
13. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
Kar HK; Sharma P
Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
[TBL] [Abstract][Full Text] [Related]
14. Comment: Persistence of Mycobacterium leprae in the peripheral nerves of multidrug-treated leprosy patients.
Grange JM; Beck JS; Abbot NC
Lepr Rev; 1993 Sep; 64(3):280. PubMed ID: 8110236
[No Abstract] [Full Text] [Related]
15. In leprosy the presence of mycobacteria in the nerve is an essential factor in the cycle and spectrum of Mycobacterium leprae infection.
Negesse Y; Beimnet K; Miko T; Wondimus A; Berhan TY
Lepr Rev; 1993 Jun; 64(2):104-9. PubMed ID: 8341112
[TBL] [Abstract][Full Text] [Related]
16. Does clofazimine (B663) reach Mycobacterium leprae persisting in Schwann cells and endothelial cells of endoneurial blood vessels in peripheral nerves?
Kumar V
Microsc Res Tech; 2008 Aug; 71(8):614-8. PubMed ID: 18567015
[TBL] [Abstract][Full Text] [Related]
17. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
[TBL] [Abstract][Full Text] [Related]
18. A clinical, immunological, and histological study of neuritic leprosy patients.
Kaur G; Girdhar BK; Girdhar A; Malaviya GN; Mukherjee A; Sengupta U; Desikan KV
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):385-91. PubMed ID: 1890361
[TBL] [Abstract][Full Text] [Related]
19. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
[TBL] [Abstract][Full Text] [Related]
20. A follow-up study of multibacillary Hansen's disease patients treated with multidrug therapy (MDT) or MDT + immunotherapy (IMT).
Rada E; Ulrich M; Aranzazu N; Rodriguez V; Centeno M; Gonzalez I; Santaella C; Rodriguez M; Convit J
Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):320-7. PubMed ID: 9401484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]